How long until you feel the effects of Wegovy?

The biggest misconception: that you should feel a dramatic change in week one

A question our prescribers hear regularly is why nothing seems to be happening after the first injection. The expectation of an immediate, obvious effect is understandable, but it misreads how semaglutide works. Wegovy is not a stimulant or a fast-acting appetite suppressant in the way some people imagine. It works by activating GLP-1 receptors that regulate hunger signalling and gastric emptying, a process that builds gradually as the medicine reaches steady levels in your system and, critically, as your dose increases.

The opening dose of 0.25 mg is a tolerability step. Its job is to settle your system into the medicine, not to produce peak appetite suppression. Most of the meaningful effect comes at higher maintenance doses reached over several months of careful titration by your prescriber. Expecting transformative results at week one from the starter dose is a little like expecting a full concert from a soundcheck. Let that expectation go gently, progress is real, just slower and quieter than the headlines suggest.

If you want a fuller picture of the early experience, still feeling hungry in your first week of Wegovy is a common concern we address separately.

Weeks one to four: what most people notice first

Within the first week or two, many people describe a subtle but genuine shift in their relationship with food. Portions feel like enough sooner. The pull toward a second serving is a little less insistent. These are not dramatic announcements, they are quiet. Some people almost miss them.

Nausea is the other frequent early companion. It tends to peak in the first days after an injection and then ease before the next dose is due. This is the body adjusting to slowed gastric emptying, and for most people it is manageable rather than severe. If you are wondering how long until Wegovy takes effect, the answer depends on starting weight, metabolic health and how sensitive you are to the medicine at low doses. The timeline of how long it takes to feel Wegovy's effects can vary between individuals for those same reasons.

Actual weight on the scale at four weeks is modest for most people. One to two kilograms is a reasonable early expectation. This is not failure, it reflects where you are in the titration schedule, not where you will end up. The NHS patient information for semaglutide sets out the side-effect and adjustment picture in detail, and it is worth reading alongside your Patient Information Leaflet.

Months two to six: when the effects of semaglutide compound

This is where the effects of semaglutide become harder to ignore. As doses increase through the schedule under prescriber supervision, appetite suppression deepens. Meals feel satisfying at smaller volumes. Many people find their food choices shift naturally, not through willpower but because cravings for calorie-dense foods simply lose some of their urgency.

Weight loss that felt slow at week four accelerates as the maintenance dose is approached. The STEP 1 trial, published in the New England Journal of Medicine, tracked 68 weeks of treatment with semaglutide 2.4 mg and recorded an average body-weight reduction of around 15%. That figure accumulated over the full trial period, not in the first month. For an honest sense of how long Wegovy takes to work across the full course, the six-month point is where most people feel the medicine has genuinely changed things.

Gastrointestinal side effects, if they were present early on, usually settle into the background by this point. Energy levels often stabilise. The physical and practical side of weekly injections becomes routine quickly for most people. Specific questions about how this experience varies individually are worth raising with your prescriber at every review.

Beyond six months: the longer picture

Wegovy is designed for sustained use as part of a broader approach that includes dietary changes and increased activity. The NICE appraisal of semaglutide for weight management (TA875) recommends it for use for a maximum of two years within a structured programme, with a review at six months to confirm that meaningful weight loss has occurred. If fewer than 5% of starting body weight has been lost by that point on the maintenance dose, continuing is assessed carefully with the prescriber.

The higher 7.2 mg dose, approved by the MHRA in early 2026, has shown average weight loss of around 20.7% over 72 weeks in trials, results that approach those seen with tirzepatide. That dose is titrated to by the same gradual schedule, starting at 0.25 mg. Which dose a person reaches, and how quickly, depends on tolerability and clinical judgement, not a fixed timetable.

Understanding what to expect before you feel Wegovy's effects fully helps people stay the course during the slower early weeks. Treatment is a long arc, and the effects accumulate rather than arrive. For a broader overview of what Wegovy involves, our Wegovy treatment page covers the full picture. If you are considering starting, our free consultation is the first step, a GPhC-registered prescriber reviews your case the same day, not software.